MY

Mohd Yahya Khan

Active Director Director DIN 09421154
DIN 09421154 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohd Yahya Khan

Data last updated:

Mohd Yahya Khan is a Director at Medrim Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals.

DIN 09421154
Primary Designation Director
Industry Chemicals
First Appointment 01 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20212021Active

Board colleagues of Mohd Yahya Khan

Directorship timeline

Open interactive timeline →
Medrim Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohd Yahya Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohd Yahya Khan

Mohd Yahya Khan currently holds 1 directorship: Medrim Pharmaceuticals Private Limited (Director, since 01 Dec 2021).

Mohd Yahya Khan was first appointed on 01 Dec 2021 as Director at Medrim Pharmaceuticals Private Limited.

The current boards of Mohd Yahya Khan's companies include Arvind Bairagi (Medrim Pharmaceuticals Private Limited), Shahdab Khan (Medrim Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available